-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Aytu Biopharma, Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2024.
- Aytu Biopharma, Inc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $352K, a 60.9% decline year-over-year.
- Aytu Biopharma, Inc Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $2.91M, a 51.8% decline year-over-year.
- Aytu Biopharma, Inc annual Share-based Payment Arrangement, Expense for 2024 was $2.91M, a 51.8% decline from 2023.
- Aytu Biopharma, Inc annual Share-based Payment Arrangement, Expense for 2023 was $6.05M, a 15.2% increase from 2022.
- Aytu Biopharma, Inc annual Share-based Payment Arrangement, Expense for 2022 was $5.25M, a 46.8% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)